|
Apr 7
|
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
|
|
Apr 7
|
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
|
|
Apr 5
|
CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation
|
|
Apr 4
|
CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know
|
|
Apr 3
|
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March
|
|
Apr 3
|
CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
|
|
Mar 14
|
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
|
|
Mar 13
|
Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?
|
|
Mar 11
|
ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics
|
|
Feb 24
|
2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street
|
|
Feb 23
|
CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts
|
|
Feb 20
|
CRISPR Therapeutics AG (CRSP): Among the Most Oversold Healthcare Stocks to Buy Now
|
|
Feb 20
|
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Feb 18
|
CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?
|
|
Feb 16
|
Street Calls of the Week
|
|
Feb 15
|
Why CRISPR Therapeutics (CRSP) Soared on Friday?
|
|
Feb 14
|
CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99
|
|
Feb 14
|
CRISPR Therapeutics Stock Upgrade Following Analyst Reassessment
|
|
Feb 12
|
Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday
|
|
Feb 12
|
Crispr Therapeutics price target raised to $86 from $85 at BofA
|